Gujarat Inject (Kerala) Ltd.
Snapshot View

View in App

Prices View details >>

6.59 ▼0%

19 September 2022, 04:01:00 PM

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.gujaratinject.com
Market Cap 3.23 Cr.
Enterprise Value(EV) 3.95 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 0.01 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 645.69 Trailing Twelve Months Ending 2022-06
Industry PE 30.55 Trailing Twelve Months Ending 2022-06
Book Value / Share -1.76 Trailing Twelve Months Ending 2022-06
Price to Book Value -3.75 Calculated using Price: 6.59
Dividend Yield 0.00 Period Ending 2021-03
No. of Shares Subscribed 0.49 Cr. 4,899,000 Shares
FaceValue 10
Company Profile
Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
1 Week
1 Month
3 Month
+15.41%
6 Month
1 Year
2 Year
5 Year
10 Year

Ratios View Details >>

9 years 2013-03 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03
Return on Equity (%)
Return on Capital Employed (%)
Return on Assets (%) -4.26 -1.68 -1.84 1,373.74 6.93 -102.49 -30.20 1.57 -664.44

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03* Rs. Cr.
Shh. Funds -3 -3 -3 -1 -1 -1 -1 -1 -1 -1
Non Curr. Liab. 0 0 0 0 0 0 0 0
Curr. Liab. 3 3 3 1 0 0 0 0 0 0
Minority Int.
Equity & Liab. 0 0 0 0 0 0 0 0 0 0
Non Curr. Assets 0
Curr. Assets 0 0 0 0 0 0 0 0 0 0
Misc. Exp. not W/O
Total Assets 0 0 0 0 0 0 0 0 0 0

Profit Loss View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 0 2 0 0
Other Income 0 0 0 0 0
Total Income 0 2 0 0 0 0 0
Total Expenditure 0 0 -2 0 0 0 0 0
PBIDT 0 0 0 0 0 0
Interest 0
Depreciation
Taxation
Exceptional Items 2
PAT 0 2 0 0 0 0 0
Adjusted EPS 0 0 0 5 0 0 0 0 0

Cash Flow View Details >>

Particulars 10 years 2012-03 Rs. Cr. 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr.
Cash Fr. Operatn. 0 0
Cash Fr. Inv.
Cash Fr. Finan. 0
Net Change 0
Cash & Cash Eqvt 0 0 0 0 0 0 0 0 0

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Public 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Wed, 14 Sep 2022
Board Meeting Outcome for Outcome Of The Board Meeting Held On Today I.E. September 14 2022 Under Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations").
With further reference to our letter dated September 07 2022 and in accordance withRegulation 30 read with Schedule III of the SEBI Listing Regulations we hereby inform youthat the Board of Directors of the Company at their Meeting held today i.e. September 14 2022 has 1. approved to create issue offer and allot upto 10000000 (One Crore) Convertible Equity Warrants ("Warrants/Convertible Warrants") on preferential basis 2. Proposed subject to the approval of shareholders increase in Authorised Share Capital of the Company from Rs. 7 00 00 000/- (Rupees Seven Crore Only) divided into 7000000 (Seventy Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) each to Rs. 15 00 00 000/- (Rupees Fifteen Crore Only) divided into 15000000 (One Crore Fifty Lakh) Equity Shares of Rs. 10/- (Rupees Ten Only) and to make consequent alteration in Clause V of the Memorandum of Association.
Wed, 14 Sep 2022
Announcement under Regulation 30 (LODR)-Issue of Securities
Board of Directors at their meeting held today has approved to create issue offer and allot upto 10000000 (One Crore) Convertible Equity Warrants ("Warrants/Convertible Warrants") on preferential basis at a price of Rupees 10.00 per Warrant or such other higher price as may be determined as on the relevant date in accordance with the SEBI (ICDR) Regulations in such a manner and upon such terms and conditions as may be deemed appropriate by the Board on preferential basis to the identified Investors subject to the approval of the Shareholders of the Company and applicable regulatory authorities as the case may be in accordance with the SEBI ICDR Regulations Companies Act 2013 and other applicable laws.
Wed, 14 Sep 2022
Announcement under Regulation 30 (LODR)-Issue of Securities
Board of Directors at their meeting held today has approved to create issue offer and allot upto 10000000 (One Crore) Convertible Equity Warrants ("Warrants/Convertible Warrants") on preferential basis at a price of Rupees 10.00 per Warrant or such other higher price as may be determined as on the relevant date in accordance with the SEBI (ICDR) Regulations in such a manner and upon such terms and conditions as may be deemed appropriate by the Board on preferential basis to the identified Investors subject to the approval of the Shareholders of the Company and applicable regulatory authorities as the case may be in accordance with the SEBI ICDR Regulations Companies Act 2013 and other applicable laws.

Technical Scans View Details >>

Mon, 19 Sep 2022
Opening at High Opening at High
Opening at Low Opening at Low
Close Within 52 Week High Zone Close Within 52 Week High Zone
High Increase 3 Months High Increase 3 Months
MFI Above 80 MFI Above 80

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 903.35 +0.3%
Divi's Laboratories Ltd. 97,676.51 3,653.90 -0.4%
Cipla Ltd. 85,998.13 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. 51,200.03 1,512.30 0.0%
Max Healthcare Institute Ltd. 40,653.72 411.10 -1.9%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-06 34.59 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 411.10 -1.9%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-06 4.00 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 411.10 -1.9%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 0.04 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 411.10 -1.9%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 411.10 -1.9%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 13.10 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 411.10 -1.9%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 411.10 -1.9%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 903.35 +0.3%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,653.90 -0.4%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,089.40 +2.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,147.90 +0.5%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,246.45 -0.8%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,512.30 0.0%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 411.10 -1.9%

FAQ's On Gujarat Inject (Kerala) Ltd.

What is Guj. Inject (Kerala) share price?
Can I buy Guj. Inject (Kerala) shares now?
What is the Market Cap of Guj. Inject (Kerala)?
What are the key metrics to analyse Guj. Inject (Kerala)?
What is the 52 Week High and Low of Guj. Inject (Kerala)?